SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACMI - Accumed Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cisco who wrote (290)9/22/1997 4:56:00 PM
From: MED TECH   of 1894
 
Thin Prep is made to be used with Cytic system and does cost more than traditional Pap smear. Some insurance carriers already approved the use of Thin Prep namely BC/BS of Ohio, a company that invests big time into Thin Prep.
ACMI uses slide tracking technology compatible with any smears.
Cytic is very successful in marketting to the consumers and the share costs more. I am not saying if you should short Cytic or not. I do not invest in Cytic due to its price and, to me, it does not offer a cheaper yet equivalent alternative to the current method. Cytic system is costly to the consumers and until the lab field embraces this technology faster than the current pace; I will stick to ACMI.
MT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News